51 results
8-K
EX-10.1
BIAF
BioAffinity Technologies Inc
5 Jun 24
Departure of Directors or Certain Officers
4:10pm
as of the time the Option with respect to such Shares is granted. The Optionee hereby acknowledges that there is no assurance that the Option
424B3
BIAF
BioAffinity Technologies Inc
22 May 24
Prospectus supplement
4:00pm
arrangements, or a combination thereof to continue to fund our operations and develop our products. There is no assurance that any such collaborative … and raise capital from financing transactions. There can be no assurance that we will be successful in accomplishing these objectives.
We continue
424B3
BIAF
BioAffinity Technologies Inc
22 May 24
Prospectus supplement
4:00pm
, or a combination thereof to continue to fund our operations and develop our products. There is no assurance that any such collaborative arrangement … financing transactions. There can be no assurance that we will be successful in accomplishing these objectives.
We continue to seek sources
424B3
owirkh vntq3
16 Apr 24
Prospectus supplement
7:19pm
POS AM
vs8v9guo cxe0
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
8-K
EX-10.1
pel 8rlacvd
8 Mar 24
Entry into a Material Definitive Agreement
5:00pm
424B5
g5xssw6 becq7
8 Mar 24
Prospectus supplement for primary offering
12:18pm
424B5
5eoidbv
7 Mar 24
Prospectus supplement for primary offering
9:57pm
424B5
jn5vvt q5
28 Nov 23
Prospectus supplement for primary offering
4:00pm
S-3
2jv5nw4n 7q1
16 Nov 23
Shelf registration
5:23pm